Cargando…
A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis
BACKGROUND: Ovarian cancer (OC) is an aggressive disease, primarily diagnosed in late stages with only 20% of patients surviving more than 5 years after diagnosis. There is a pending need to improve current diagnostics and prognostics. METHODS: In this study, we investigated total circulating cell-f...
Autores principales: | Gahlawat, Aoife Ward, Witte, Tania, Haarhuis, Lisa, Schott, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553930/ https://www.ncbi.nlm.nih.gov/pubmed/35931806 http://dx.doi.org/10.1038/s41416-022-01925-0 |
Ejemplares similares
-
Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2023) -
Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2022) -
Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies
por: Ward Gahlawat, Aoife, et al.
Publicado: (2019) -
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
por: Cardinali, Barbara, et al.
Publicado: (2022) -
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020)